Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lineage

56.78
-0.9900-1.71%
Post-market: 56.780.00000.00%17:45 EDT
Volume:1.10M
Turnover:63.14M
Market Cap:12.96B
PE:-15.35
High:59.64
Open:57.64
Low:56.76
Close:57.77
Loading ...

Exclusive: Kaia Blockchain Debunks Soneium-LINE Partnership Claims, Vows Objections

CoinMarketCap
·
Yesterday

Lineage Cell Therapeutics Faces Uncertainty Amid New U.S. Administration’s Policies

TIPRANKS
·
12 Mar

Lineage Cell Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
11 Mar

MAISONS DU MONDE: ANNUAL RESULTS 2024 IN LINE WITH GUIDANCE: Positive free cash flow / Net Sales € 1.002 billion / Visible effects of Inspire Everyday expected in 2025, with a gradual return to growth

GlobeNewswire
·
11 Mar

Lineage Cell Therapeutics: 2024 Financial Results and Strategic Progress

TIPRANKS
·
11 Mar

Lineage management to meet with Piper Sandler

TIPRANKS
·
11 Mar

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Business Wire
·
11 Mar

Lineage Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
11 Mar

Lineage price target raised to $74 from $73 at Scotiabank

TIPRANKS
·
10 Mar

AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

PR Newswire
·
08 Mar

Lineage Is Maintained at Outperform by RBC Capital

Dow Jones
·
06 Mar

Lineage, Inc. (LINE) Receives a Buy from Bank of America Securities

TIPRANKS
·
06 Mar

Lineage price target lowered to $74 from $81 at RBC Capital

TIPRANKS
·
06 Mar

RBC Cuts Price Target on Lineage to $74 From $81, Keeps Outperform Rating

MT Newswires Live
·
06 Mar

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025

Business Wire
·
05 Mar

Lineage price target lowered to $71 from $77 at Goldman Sachs

TIPRANKS
·
04 Mar